Literature DB >> 17630354

Notch signaling induces cytoplasmic CD3 epsilon expression in human differentiating NK cells.

Magda De Smedt1, Tom Taghon, Inge Van de Walle, Greet De Smet, Georges Leclercq, Jean Plum.   

Abstract

It has been proposed that heterogeneity in natural killer (NK)-cell phenotype and function can be achieved through distinct thymic and bone marrow pathways of NK-cell development. Here, we show a link between Notch signaling and the generation of intracellular CD3epsilon (cyCD3)-expressing NK cells, a cell population that can be detected in vivo. Differentiation of human CD34(+) cord blood progenitors in IL-15-supplemented fetal thymus organ culture or OP9-Delta-like 1 (DL1) coculture resulted in a high percentage of cyCD3(+) NK cells that was blocked by the gamma-secretase inhibitor DAPT. The requirement for Notch signaling to generate cyCD3(+) NK cells was further illustrated by transduction of CD34(+) cord blood (CB) cells with either the active intracellular part of Notch or the dominant-negative mutant of mastermind-like protein 1 that resulted in the generation of NK cells with respectively high or low frequencies of cyCD3. Human thymic CD34(+) progenitor cells displayed the potential to generate cyCD3(+) NK cells, even in the absence of Notch/DL1 signaling. Peripheral blood NK cells were unable to induce cyCD3 expression after DL1 exposure, indicating that Notch-dependent cyCD3 expression can only be achieved during the early phase of NK-cell differentiation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17630354     DOI: 10.1182/blood-2007-03-082206

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  19 in total

Review 1.  Molecular mechanisms that control mouse and human TCR-alphabeta and TCR-gammadelta T cell development.

Authors:  Tom Taghon; Ellen V Rothenberg
Journal:  Semin Immunopathol       Date:  2008-10-17       Impact factor: 9.623

2.  The heterogeneity of human CD127(+) innate lymphoid cells revealed by single-cell RNA sequencing.

Authors:  Åsa K Björklund; Marianne Forkel; Simone Picelli; Viktoria Konya; Jakob Theorell; Danielle Friberg; Rickard Sandberg; Jenny Mjösberg
Journal:  Nat Immunol       Date:  2016-02-15       Impact factor: 25.606

3.  Jagged2 acts as a Delta-like Notch ligand during early hematopoietic cell fate decisions.

Authors:  Inge Van de Walle; Greet De Smet; Martina Gärtner; Magda De Smedt; Els Waegemans; Bart Vandekerckhove; Georges Leclercq; Jean Plum; Jon C Aster; Irwin D Bernstein; Cynthia J Guidos; Bruno Kyewski; Tom Taghon
Journal:  Blood       Date:  2011-03-03       Impact factor: 22.113

4.  The Notch ligands Jagged2, Delta1, and Delta4 induce differentiation and expansion of functional human NK cells from CD34+ cord blood hematopoietic progenitor cells.

Authors:  Rose C Beck; Mallika Padival; David Yeh; Justine Ralston; Kenneth R Cooke; John B Lowe
Journal:  Biol Blood Marrow Transplant       Date:  2009-09       Impact factor: 5.742

5.  In Vitro Generation of Human NK Cells Expressing Chimeric Antigen Receptor Through Differentiation of Gene-Modified Hematopoietic Stem Cells.

Authors:  Emily Lowe; Laurel C Truscott; Satiro N De Oliveira
Journal:  Methods Mol Biol       Date:  2016

6.  Age-associated changes in the differentiation potentials of human circulating hematopoietic progenitors to T- or NK-lineage cells.

Authors:  Seishi Kyoizumi; Yoshiko Kubo; Junko Kajimura; Kengo Yoshida; Kazue Imai; Tomonori Hayashi; Kei Nakachi; Lauren F Young; Malcolm A Moore; Marcel R M van den Brink; Yoichiro Kusunoki
Journal:  J Immunol       Date:  2013-05-13       Impact factor: 5.422

7.  Notch regulates cytolytic effector function in CD8+ T cells.

Authors:  Ok Hyun Cho; Hyun Mu Shin; Lucio Miele; Todd E Golde; Abdul Fauq; Lisa M Minter; Barbara A Osborne
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

8.  Notch Regulates Innate Lymphoid Cell Plasticity during Human NK Cell Development.

Authors:  Ansel P Nalin; Jesse J Kowalski; Alexander C Sprague; Blaire K Schumacher; Adam G Gerhardt; Youssef Youssef; Kiran V Vedantam; Xiaoli Zhang; Christian W Siebel; Emily M Mace; Michael A Caligiuri; Bethany L Mundy-Bosse; Aharon G Freud
Journal:  J Immunol       Date:  2020-10-05       Impact factor: 5.422

9.  Activated notch supports development of cytokine producing NK cells which are hyporesponsive and fail to acquire NK cell effector functions.

Authors:  Veronika Bachanova; Valarie McCullar; Todd Lenvik; Rosanna Wangen; Karen A Peterson; Dave E M Ankarlo; Angela Panoskaltsis-Mortari; John E Wagner; Jeffrey S Miller
Journal:  Biol Blood Marrow Transplant       Date:  2009-02       Impact factor: 5.742

10.  Modification of hematopoietic stem/progenitor cells with CD19-specific chimeric antigen receptors as a novel approach for cancer immunotherapy.

Authors:  Satiro Nakamura De Oliveira; Christine Ryan; Francesca Giannoni; Cinnamon L Hardee; Irena Tremcinska; Behrod Katebian; Jennifer Wherley; Arineh Sahaghian; Andy Tu; Tristan Grogan; David Elashoff; Laurence J N Cooper; Roger P Hollis; Donald B Kohn
Journal:  Hum Gene Ther       Date:  2013-10       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.